A novel virtual screening procedure identifies Pralatrexate as inhibitor of SARS-CoV-2 RdRp and it reduces viral replication in vitro. - Haiping Zhang; Yang Yang; Junxin Li; Min Wang; Konda Mani Saravanan; Jinli Wei; Justin Tze-Yang Ng; Md. Tofazzal Hossain; Maoxuan Liu; Huiling Zhang; Xiaohu Ren; Yi Pan 001; et al. (PLoS Comput. Biol., 2020)